Back to search
FDAFDA · Food and drugs·Recall number D-0090-2024

Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10

Published November 15, 2023 · Recall initiated: October 27, 2023

Summary

FDA records drug Class II recall D-0090-2024, published November 15, 2023 and initiated October 27, 2023. Recalling firm: Amneal Pharmaceuticals of New York, LLC; Status: Terminated; Reported quantity: 9,263 100-count bottles; Lot: Lot # HM03221A, Exp. date 12/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if EXTENDED PHENYTOIN SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EXTENDED PHENYTOIN SODIUM
Manufacturer
Amneal Pharmaceuticals of New York, LLC
Distributor
Nationwide in the USA and Puerto Rico
UPC
0365162212037
Lot
Lot # HM03221A, Exp. date 12/31/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10 recalled?

Yes. FDA published recall D-0090-2024 on November 15, 2023. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EXTENDED PHENYTOIN SODIUM. UPC: 0365162212037.